International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 12 , ISSUE 1 ( January-April, 2021 ) > List of Articles

RESEARCH ARTICLE

Seminal Levels of Immunoglobulins and Complements and Their Relationship with Seminal Parameters in Chronic Hemodialytic Patients

Gilmar P Silva, Vítor PX Grangeiro, Carmelita FD Oliveira

Keywords : Chronic kidney disease, Complement, Immunity, Immunoglobulins, Male infertility

Citation Information : Silva GP, Grangeiro VP, Oliveira CF. Seminal Levels of Immunoglobulins and Complements and Their Relationship with Seminal Parameters in Chronic Hemodialytic Patients. Int J Infertil Fetal Med 2021; 12 (1):13-16.

DOI: 10.5005/jp-journals-10016-1214

License: CC BY-NC 4.0

Published Online: 00-04-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim and objective: To investigate the potential relationship between seminal complements (C3 and C4) and immunoglobulin (IgA and IgG) levels and seminal parameters (SPs) in chronic hemodialysis patients. Materials and methods: A cross-sectional study was conducted among patients aged between 18 years and 60 years. The sample comprises 60 males undergoing hemodialysis for >6 months, and 15 healthy males without clinical or laboratory signs of genitourinary and eugonadic tract infections. Spermograms and leukocytopermia, serum hormonal profiles, and seminal measurements of complement fractions (C3, C4) and immunoglobulins (IgA, IgG) were performed. Results: The hemodialysis and healthy groups were similar in age (49.47 ± 05.55 and 50.53 ± 04.24 years, p = 0.06). Average levels of seminal C fractions (C3, C4) were similar between the hemodialysis and healthy groups, between normozoospermia and oligozoospermia hemodialysis subgroups, and in the oligozoospermia hemodialysis subgroup. Average seminal levels of Igs (A and G) differed significantly between the hemodialysis and healthy groups (351.60 ± 035.80 vs 247.40 ± 39.00 mg/L), and in normozoospermia and oligozoospermia hemodialysis subgroups (361.20 ± 36.30 vs 340.60 ± 32.50 mg/L). However, they were similar (p > 0.05) between subgroups of oligozoospermia. The seminal fractions of complete (C3 and C4) and Ig (A and G) did not correlate (p > 0.05) with SPs. All participants had hormonal profiles within the normal range. Conclusion: The complement fractions (C3 and C4) and immunoglobulins (IgA and IgG) showed no relationship with SPs in chronic hemodialysis patients.


PDF Share
  1. Sergeant N, Mitchell V, Jumeau F, et al. Methods for determining human sperm quality. Google Patents 2017.
  2. Gupta R, Kaur S, Bhagat B, et al. Epidemiology of infertility patients with abnormal semen parameters. Indian J Appl Res 2019;9(7):e5122.
  3. Hamilton JAM, Cissen M, Brandes M, et al. Total motile sperm count: a better indicator for the severity of male factor infertility than the WHO sperm classification system. Hum Reprod 2015;30(5):1110–1121. DOI: 10.1093/humrep/dev058.
  4. Neuzillet Y, Thuret R, Kleinclauss F, et al. Andrologic consequences of chronic renal failure: state of the art for the yearly scientific report of the French National Association of Urology. Prog Urol 2016;26(15):1088–1093. DOI: 10.1016/j.purol.2016.08.013.
  5. Dumanski SM, Ahmed SB. Fertility and reproductive care in chronic kidney disease. J Nephrol 2019;32(1):39–50. DOI: 10.1007/s40620-018-00569-9.
  6. Raj DS, Pecoits-Filho R, Kimmel PL. Inflammation in chronic kidney disease. Chronic Renal Disease. Elsevier; 2020. pp. 355–373.
  7. Russa DL, Pellegrino D, Montesanto A, et al. Oxidative balance and inflammation in hemodialysis patients: biomarkers of cardiovascular risk? Oxidat Med Cellu longev 2019;2019:8567275. DOI: 10.1155/2019/8567275.
  8. Poppelaars F, Faria B, Gaya da Costa M, et al. The complement system in dialysis: a forgotten story? Front Immunol 2018;9:71. DOI: 10.3389/fimmu.2018.00071.
  9. Prem AR, Punekar SV, Kalpana M, et al. Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation. Br J Urol 1996;78(4):635–638. DOI: 10.1046/j.1464-410X.1996.14624.x.
  10. Yilmaz MI, Carrero JJ, Axelsson J, et al. Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences. Clin Nephrol 2007;68(1):1–9. DOI: 10.5414/CNP68001.
  11. Brazdova A, Senechal H, Peltre G, et al. Immune aspects of female infertility. Int J Fertil Steril 2016;10(1):1.
  12. Organization WH, WHO laboratory manual for the examination and processing of human semen. 2010.
  13. Said TM, Agarwal A. Tests for sperm antibodies. Immune Infertility. Springer; 2017. pp. 197–207.
  14. Delanghe JR, Speeckaert R, Speeckaert MM. Complement C3 and its polymorphism: biological and clinical consequences. Pathology 2014;46(1):1–10. DOI: 10.1097/PAT.0000000000000042.
  15. Limam M, Zorgati M, Zarrouk A, et al. IgG and IgA levels determination in semen liquid: interest for the biological investigation of infertility. Ann Biol Clin (Paris)+A4255 2009;67(6):613–617.
  16. Merle NS, Noe R, Halbwachs-Mecarelli L, et al. Complement system part II: role in immunity. Front Immunol 2015;6:257. DOI: 10.3389/fimmu.2015.00257.
  17. Sun Y, Huang T, Hammarstrom L, et al. The immunoglobulins: new insights, implications, and applications. Annu Rev Anim Biosci 2020;8(1):145–169. DOI: 10.1146/annurev-animal-021419-083720.
  18. Silva JAF, Biancardi MF, Stach-Machado DR, et al. The origin of prostate gland-secreted IgA and IgG. Sci Rep 2017;7(1):16488. DOI: 10.1038/s41598-017-16717-3.
  19. Toama R, Al-Salman AR, Al-Barrak AAY. Study of the immunological state of patients with idiopathic male infertility. Med J Baby 2006;3(3-4):246–254.
  20. Rahimi A, Sepehri H, Pakravesh J, et al. Quantification of C3 and C4 in infertile men with antisperm antibody in their seminal plasma. Am J Reprod Immunol 1999;41(5):330–336. DOI: 10.1111/j.1600-0897.1999.tb00446.x.
  21. Ghebrehiwet B. The complement system: an evolution in progress. F1000 Res 2016;5:2840. DOI: 10.12688/f1000research.10065.1.
  22. Azenabor A, Ekun AO, Akinloye O. Impact of inflammation on male reproductive tract. J Reproduct Infertil 2015;16(3):123–129.
  23. Qu N, Ogawa Y, Kuramasu M, et al. Immunological microenvironment in the testis. Reproduct Med Biol 2020;19(1):24–31. DOI: 10.1002/rmb2.12293.
  24. Archana SS, Selvaraju S, Binsila BK, et al. Immune regulatory molecules as modifiers of semen and fertility: a review. Molecul Reproduct Develop 2019(11). DOI: 10.1002/mrd.23263.
  25. Fijak M, Bhushan S, Meinhardt A. The immune privilege of the testis. Immune Infertil. Springer; 2017. pp. 97–107.
  26. Chen Q, Deng T, Han D. Testicular immunoregulation and spermatogenesis. Semin Cell Dev Biol 2016;59:157–165. DOI: 10.1016/j.semcdb.2016.01.019.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.